Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Veracyte, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
VCYT
Nasdaq
2830
www.veracyte.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Veracyte, Inc.
Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer
- Oct 23rd, 2026 2:00 am
Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?
- Oct 21st, 2026 9:10 am
Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
- Oct 19th, 2026 6:00 am
Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence Test
- Oct 16th, 2026 7:15 am
Natera Gains 118.1% in a Year: What's Driving the Rally?
- Oct 15th, 2026 6:28 am
Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026
- Oct 14th, 2026 2:05 pm
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms
- Oct 13th, 2026 8:03 am
Mammogen Appoints Diagnostics Industry Leader, Dr. Robert S. Epstein, to Board of Directors
- Oct 13th, 2026 5:02 am
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
- Oct 9th, 2026 7:58 am
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
- Oct 9th, 2026 7:43 am
Veracyte (VCYT) Stock Still Looks Cheap As Its 107% Run Continues
- Oct 8th, 2026 11:13 pm
Is it the Right Time to Add Phibro Stock to Your Portfolio?
- Oct 8th, 2026 10:22 am
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
- Oct 8th, 2026 10:18 am
Bruker Gains 66.3% in a Year: What's Driving the Rally?
- Oct 8th, 2026 7:39 am
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
- Oct 7th, 2026 7:11 am
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
- Oct 7th, 2026 6:52 am
Charles River Gains 75.8% in a Year: What's Driving the Rally?
- Oct 7th, 2026 6:51 am
Reasons to Add Globus Medical Stock to Your Portfolio Now
- Oct 7th, 2026 6:51 am
Is This the Right Time to Add TMO Stock to Your Portfolio?
- Oct 7th, 2026 6:45 am
Scroll